Anne Edelstein is an investor for Counterpoint Global. She joined Morgan Stanley in 2018 and has 13 years of investment experience. Prior to joining the firm, she was a Vice President and Equity Research Analyst at Bank of America Merrill Lynch (BAML) following life science tools and diagnostics. She previously covered semiconductors and specialty pharmaceuticals, also for BAML. Anne earned a B.A. in neuroscience at Hamilton College.
Anne is a member of Counterpoint Global


This is a Marketing Communication.

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Your Privacy Choices Your Privacy Choices Icon    •    Terms of Use

©  Morgan Stanley. All rights reserved.